JP2003292459A5 - - Google Patents

Download PDF

Info

Publication number
JP2003292459A5
JP2003292459A5 JP2003059191A JP2003059191A JP2003292459A5 JP 2003292459 A5 JP2003292459 A5 JP 2003292459A5 JP 2003059191 A JP2003059191 A JP 2003059191A JP 2003059191 A JP2003059191 A JP 2003059191A JP 2003292459 A5 JP2003292459 A5 JP 2003292459A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2003059191A
Other versions
JP4740524B2 (ja
JP2003292459A (ja
Filing date
Publication date
Priority claimed from TW91101510A external-priority patent/TWI299667B/zh
Priority claimed from CNB021032564A external-priority patent/CN1224424C/zh
Application filed filed Critical
Publication of JP2003292459A publication Critical patent/JP2003292459A/ja
Publication of JP2003292459A5 publication Critical patent/JP2003292459A5/ja
Application granted granted Critical
Publication of JP4740524B2 publication Critical patent/JP4740524B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2003059191A 2002-01-30 2003-01-29 熱応答粘膜接着性医薬−担体組成物 Expired - Lifetime JP4740524B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
TW091101510 2002-01-30
TW91101510A TWI299667B (en) 2002-01-30 2002-01-30 A mucoadhesive thermoresponsive medicament-carrier composition
CNB021032564A CN1224424C (zh) 2002-02-01 2002-02-01 粘膜吸附性的热凝性医药载体组合物

Publications (3)

Publication Number Publication Date
JP2003292459A JP2003292459A (ja) 2003-10-15
JP2003292459A5 true JP2003292459A5 (ja) 2005-10-27
JP4740524B2 JP4740524B2 (ja) 2011-08-03

Family

ID=30116452

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003059191A Expired - Lifetime JP4740524B2 (ja) 2002-01-30 2003-01-29 熱応答粘膜接着性医薬−担体組成物

Country Status (2)

Country Link
US (2) US20040009212A1 (ja)
JP (1) JP4740524B2 (ja)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7932365B2 (en) 2003-11-08 2011-04-26 Pro Thera Biologics, Llc Preparation and composition of inter-alpha inhibitor proteins from human plasma for therapeutic use
DE602006018578D1 (de) 2005-01-28 2011-01-13 Childrens Medical Center Diagnose- und prognoseverfahren von blasenkrebs.
US7851189B2 (en) * 2005-03-07 2010-12-14 Boston Scientific Scimed, Inc. Microencapsulated compositions for endoluminal tissue engineering
WO2006133349A2 (en) * 2005-06-08 2006-12-14 Alpharma, Inc. Orally disintegrable sleep aid formulations
WO2007136633A2 (en) * 2006-05-18 2007-11-29 Ceramoptec Industries, Inc. Gel-formulations of hydrophobic photosensitizers for mucosal applications
US20080279921A1 (en) * 2007-05-07 2008-11-13 Ceramoptec Industries, Inc. Gel-formulations of hydrophobic photosensitizers for mucosal applications
WO2009073457A1 (en) * 2007-11-30 2009-06-11 Bausch & Lomb Incorporated Methods and compositions for the rescue of a filtering bleb
CA2726281C (en) 2008-05-28 2023-04-18 Prothera Biologics, Llc Preparation and composition of inter-alpha inhibitor proteins from blood
KR100935711B1 (ko) 2008-09-12 2010-01-07 김희구 생약 패드
GB0823472D0 (en) * 2008-12-23 2009-01-28 Photocure Asa Product
US20100256125A1 (en) * 2009-04-06 2010-10-07 Zila Pharmaceuticals, Inc. Use of improved toluidine blue in photodynamic therapy
NZ596943A (en) * 2009-06-11 2013-09-27 Photocure Asa Semi-solid compositions and pharmaceutical products
CN102482338B (zh) 2009-07-10 2016-09-28 斯路姆基因公司 纤溶酶原和纤溶酶的变体
ES2534911T3 (es) 2009-08-28 2015-04-30 Thrombogenics N.V. Uso de plasmina para el tratamiento de fallo de filtración después de trabeculectomía
SG10201912526TA (en) 2009-10-01 2020-02-27 Adare Pharmaceuticals Inc Orally administered corticosteroid compositions
DE212011100034U1 (de) * 2010-01-20 2012-07-04 Theracoat Ltd. Material zur Behandlung von inneren Hohlräumen
US10471150B2 (en) * 2010-01-20 2019-11-12 Urogen Pharma Ltd. Material and method for treating internal cavities
MX337248B (es) 2011-01-05 2016-02-19 Thrombogenics Nv Variantes de plasminogeno y plasmina.
JP6076962B2 (ja) 2011-04-01 2017-02-08 フロリダ大学 リサーチファウンデーション インコーポレイティッド 治療薬を局所送達するための感熱性を有する粘膜付着性または皮膚粘着性の浸透促進剤
EP2734187B1 (en) * 2011-07-20 2018-09-05 UroGen Pharma Ltd. Materials and method for treating internal body cavities
WO2013024074A1 (en) 2011-08-12 2013-02-21 Thrombogenics N.V. Plasminogen and plasmin variants
RU2635466C2 (ru) * 2012-04-08 2017-11-13 Теракоат Лтд Препараты термообратимого гидрогеля для применения при лечении нарушений уротелия
FR2994844B1 (fr) * 2012-08-31 2015-01-02 Assist Publ Hopitaux De Paris Formulation gelifiante a base de ketamine
WO2014039987A2 (en) 2012-09-09 2014-03-13 Prothera Biologics, Inc. Treatment of disease using inter-alpha inhibitor proteins
US11931227B2 (en) 2013-03-15 2024-03-19 Cook Medical Technologies Llc Bimodal treatment methods and compositions for gastrointestinal lesions with active bleeding
WO2015034678A2 (en) 2013-09-06 2015-03-12 Aptalis Pharmatech, Inc. Corticosteroid containing orally disintegrating tablet compositions for eosinophilic esophagitis
US9801854B1 (en) * 2014-01-17 2017-10-31 Urogen Pharma Ltd. Slow release formulations of cell cycle regulators and anti-cancer agents for local treatment of solid cancer
AR100864A1 (es) * 2014-06-09 2016-11-09 Klox Tech Inc Composiciones biofotónicas termoendurecibles y sus usos
WO2016025394A2 (en) 2014-08-11 2016-02-18 Board Of Supervisors Of Louisiana State University And Agriculatural And Mechanical College Delivery of bioactive, nanoencapsulated antioxidants
DE102016001176A1 (de) * 2016-02-03 2017-08-03 Audi Ag Kraftfahrzeug
TWI728172B (zh) 2016-08-18 2021-05-21 美商愛戴爾製藥股份有限公司 治療嗜伊紅性食道炎之方法
EP3833401A4 (en) * 2018-08-06 2022-04-27 Oregon Health & Science University NERVE SPECIFIC FLUOROPHORE FORMULATIONS FOR DIRECT AND SYSTEMIC ADMINISTRATION
CN112043827B (zh) * 2019-05-20 2023-10-20 复旦大学 温敏性药物组合物、透皮制剂及其制备方法和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0551626A1 (en) * 1991-12-19 1993-07-21 LEK, tovarna farmacevtskih in kemicnih izdelkov, d.d. Thermoreversible gel as a liquid pharmaceutical carrier for a galenic formulation
MX9504023A (es) * 1994-09-20 1997-05-31 Johnson & Johnson Composicion farmaceutica y transdermicamente activa que contiene acido 5-aminolaevulinico y procedimiento para su preparacion.
US6280745B1 (en) * 1997-12-23 2001-08-28 Alliance Pharmaceutical Corp. Methods and compositions for the delivery of pharmaceutical agents and/or the prevention of adhesions
DE19744811C2 (de) * 1997-10-02 1999-11-18 Medac Klinische Spezialpraep Verwendung von delta-Aminolävulinsäure zur Herstellung eines topischen Arzneimittels zur integralen Diagnose und/oder Therapie von Tumoren in Hohlorganen
JP2002534377A (ja) * 1999-01-08 2002-10-15 スリーエム イノベイティブ プロパティズ カンパニー 免疫応答調節因子を用いて粘膜関連の病態を治療するための製剤および方法
WO2000041732A1 (en) * 1999-01-19 2000-07-20 The Children's Hospital Of Philadelphia Hydrogel compositions for controlled delivery of virus vectors and methods of use thereof

Similar Documents

Publication Publication Date Title
BE2015C007I2 (ja)
BE2014C055I2 (ja)
BE2014C027I2 (ja)
BE2014C003I2 (ja)
BE2013C075I2 (ja)
BE2013C069I2 (ja)
BE2013C067I2 (ja)
BE2013C038I2 (ja)
BE2013C036I2 (ja)
BE2011C030I2 (ja)
BE2015C005I2 (ja)
BE2012C053I2 (ja)
BE2015C024I2 (ja)
AU2002318342A1 (ja)
AU2003207787A1 (ja)
AU2002329412A1 (ja)
AU2002331433A1 (ja)
AU2002332887A1 (ja)
AU2002333044A1 (ja)
AU2002337949A1 (ja)
AU2002339901A1 (ja)
AU2002340206A1 (ja)
AU2002348177A1 (ja)
AU2002351829A1 (ja)
AU2002353888A1 (ja)